Centaur Animal Health Appoints New President and Chief Executive Officer
KANSAS CITY, Kan. and PHILADELPHIA, Aug. 27, 2013 /PRNewswire/ — Centaur Animal Health, is pleased to announce the appointment of Jeffrey Boily as President, CEO, and Director effective September 1, 2013.
Mark Metrokotsas, who has been the CEO, will become Chairman of Centaur’s Board of Directors.
Boily brings over 30 years of global life sciences experience in pharmaceuticals, biotechnology, drug delivery and animal health and will be instrumental in accelerating plans toward Centaur becoming a major animal health company. Centaur has established a track record of successful execution on product initiatives and is aggressively looking to in-license additional products.
“I’m delighted to lead Centaur Animal Health as we embark on the next phase of growth,” said Boily.
“Jeff’s background as an entrepreneurial leader and his experience in fund-raising and partnering with large and small firms is a perfect fit for Centaur,” said Mark Metrokotsas, Board Chair for Centaur Animal Health.
Jeffrey Boily is non-executive Chairman of ProteaPex Therapeutics, a firm researching and developing innovative animal health therapeutics. Most recently he was President and CEO of the Center for Animal Health Innovation which focused on identifying and funding breakthrough technologies. Previous to this, he was CEO of BioWizard, a VC funded research and information firm for biomedical scientists. He gained large company executive experience at Abbott, Rogers and Wyeth including Fort Dodge Animal Health. He holds an M.B.A. from the John Molson School of Business, Concordia U., Montreal and a B.S. in biology from the U. of Ottawa. He also serves on the Board of Directors of various healthcare companies.
About Centaur Animal Health
Centaur Animal Health is focused on developing innovative diagnostics, pharmaceuticals and nutraceuticals that address significant therapeutic needs for companion and production animals. Centaur licenses patent-protected technologies acquired from animal health or human pharmaceutical and biotechnology companies. Contract manufacturing is available in their FDA certified plant. For more information, please visit www.centauranimalhealth.com
For Media:
Ashley Hayes
Centaur Animal Health
O: (913) 390-6184
Ashley.Hayes@centauranimalhealth.com
Web Site: https://www.centauranimalhealth.com